14 November 2023

PEGs Europe

Lisbon, Portugal

We’re excited to exhibiting at PEGs Europe from 14-16 November 2023 in booth #347, an event focused on protein and antibody engineering!

Our team including Jonathan Cruickshank (Head of EU/ROW sales), Ji-Won Choi (Senior Director, Client Engagement), Patrick Hada (VP of Business Development) and Erika Kovacs (Senior Director, Bioassays), will be in Lisbon to showcase our capabilities from lead discovery and candidate selection through the manufacture of drug substance for both bioconjugates and complex biologics.  Whether you’re developing a monoclonal antibody (mABs),  ADC, oligonucleotide, vaccine, or radioconjugate, come by our booth to discuss your drug development needs with our experts and learn how we can rapidly move your program forward faster.

While you’re at PEGs Europe, make sure to attend our presentation and poster sessions at the event. On Day 1 of the conference at 15:40, our Manager of Protein Engineering, Dr Thomas Cornell, will also be giving a talk on optimisation and developability entitled: “Advanced computational Tools and Experimental methods to approach antibody developability.”

Make sure to also swing by our poster at stand A012 to hear Erika Kovacs discuss: Analytics and Bioassays to Accelerate Biologic and Bioconjugate Development.  If you’d like a copy of this poster

Click Here if you’d like a copy of our poster or to schedule a meeting.

About our speaker

Thomas Cornell, Ph.D., Senior manager, Protein Engineering, Protein Engineering, Abzena

Tom Cornell gained his Ph.D from Kings College London in the field of Chemical Biology. He then moved into the biotech startup space and spent almost a decade in preclinical vaccine research and development, focused on subunit vaccines. After working on over 20 protein families, Tom has gained a wealth of protein engineering experience. Tom joined Abzena almost 2 years ago and works within the protein engineering department working on pre-clinical development of Antibody drug candidates.